Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth.

Cameselle-Teijeiro J, Pardal F, Eloy C, Ruiz-Ponte C, Celestino R, Castro P, Soares P, Sobrinho-Simões M.

Hum Pathol. 2008 Oct;39(10):1540-7. doi: 10.1016/j.humpath.2008.01.014. Epub 2008 Jul 7.

PMID:
18602667
2.

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE.

J Clin Endocrinol Metab. 2003 May;88(5):2318-26.

PMID:
12727991
3.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

4.

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.

Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J.

Endocr Relat Cancer. 2010 Jun 3;17(3):599-610. doi: 10.1677/ERC-09-0069. Print 2010 Sep.

5.

A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.

Castro P, Roque L, Magalhães J, Sobrinho-Simões M.

Int J Surg Pathol. 2005 Jul;13(3):235-8.

PMID:
16086077
6.

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.

J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. Epub 2005 Oct 11.

PMID:
16219715
7.
8.

[Pathogenesis of differentiated thyroid cancer (papillary and follicular)].

Maciel RM, Kimura ET, Cerutti JM.

Arq Bras Endocrinol Metabol. 2005 Oct;49(5):691-700. Epub 2006 Jan 23. Review. Portuguese.

9.

Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients.

Mochizuki K, Kondo T, Oishi N, Tahara I, Inoue T, Kasai K, Nakazawa T, Okamoto T, Shibata N, Katoh R.

Pathol Int. 2015 May;65(5):250-3. doi: 10.1111/pin.12270. Epub 2015 Feb 23.

PMID:
25708358
10.

Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE.

Cancer Cytopathol. 2010 Feb 25;118(1):17-23. doi: 10.1002/cncy.20063.

11.

[Oncogenes and thyroid tumors].

Lacroix L, Soria JC, Bidart JM, Schlumberger M.

Bull Cancer. 2005 Jan;92(1):37-43. Review. French.

13.

Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

Giordano TJ, Au AY, Kuick R, Thomas DG, Rhodes DR, Wilhelm KG Jr, Vinco M, Misek DE, Sanders D, Zhu Z, Ciampi R, Hanash S, Chinnaiyan A, Clifton-Bligh RJ, Robinson BG, Nikiforov YE, Koenig RJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1983-93.

14.

Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.

Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, Schierle K, Gimm O, Dralle H, Steinert F, Sheu SY, Schmid KW, Fuhrer D.

Am J Pathol. 2011 Dec;179(6):3066-74. doi: 10.1016/j.ajpath.2011.08.033. Epub 2011 Oct 6.

15.

Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.

Banito A, Pinto AE, Espadinha C, Marques AR, Leite V.

Clin Endocrinol (Oxf). 2007 Nov;67(5):706-11. Epub 2007 Jul 25.

PMID:
17651453
16.

[Gene abnormalities in thyroid cancer].

Namba H, Yamashita S.

Nihon Rinsho. 2007 Nov;65(11):1967-72. Review. Japanese.

PMID:
18018556
17.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, Clifton-Bligh R, Robinson BG, Lui WO, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9. Epub 2005 Dec 13.

PMID:
16352687
18.

Analysis of RAS mutation and PAX8/PPARγ rearrangements in follicular-derived thyroid neoplasms in a Korean population: frequency and ultrasound findings.

Jeong SH, Hong HS, Kwak JJ, Lee EH.

J Endocrinol Invest. 2015 Aug;38(8):849-57. doi: 10.1007/s40618-015-0311-x. Epub 2015 May 22.

PMID:
25999051
19.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

20.

Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings.

Frau DV, Lai ML, Caria P, Dettori T, Coni P, Faa G, Morandi L, Tallini G, Vanni R.

J Clin Endocrinol Metab. 2008 Jan;93(1):177-81. Epub 2007 Oct 23.

PMID:
17956956

Supplemental Content

Support Center